RBBP5 Antibody

Figure 1. ChIP results obtained with the Diagenode antibody directed against RBBP5
ChIP assays were performed using K562 cells, the Diagenode antibody against RBBP5 (Cat. No. C15410342) and optimized PCR primer sets for qPCR. ChIP was performed with the “iDeal ChIP-seq” kit (cat. No. C01010055), using sheared chromatin from 4 million cells. A titration consisting of 1, 2 and 5 μg of antibody per ChIP experiment was analyzed. IgG (2 μg/IP) was used as a negative IP control. Quantitative PCR was performed with primers for the promoters of the ACTB and EIF2S3 genes, used as positive controls, and for the MYOD1 gene and the Sat2 satellite repeat, used as negative controls. Figure 1 shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).

Figure 2. ChIP-seq results obtained with the Diagenode antibody directed against RBBP5
ChIP was performed on sheared chromatin from 4 million K562 cells using 2 μg of the Diagenode antibody against RBBP5 (Cat. No. C15410342) as described above. The IP’d DNA was subsequently analysed on an Illumina HiSeq. Library preparation, cluster generation and sequencing were performed according to the manufacturer’s instructions. The 50 bp tags were aligned to the human genome using the BWA algorithm. Figure 2 shows the enrichment along the complete sequence and a 300 kb region of human chromosome 1 (fig 2A and B), and in two genomic regions surrounding the ACTB and EIF2S3 positive control genes (fig 2C and D).

Figure 3. Western blot analysis using the Diagenode antibody directed against RBBP5
Whole cell extracts from HeLa cells were analysed by Western blot using the Diagenode antibody against RBBP5 (Cat. No. C15410342) diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is indicated on the right; the marker (in kDa) is shown on the left.

Figure 4. Immunoprecipitation using the Diagenode antibody directed against RBBP5
Immunoprecipitation was performed on whole cell extracts from 293T cells using 10 μg of the Diagenode antibody against RBBP5 (Cat. No. C15410342, lane 1). An equal amount of rabbit IgG was used as a negative control (lane 2). The immunoprecipitated CBX2 protein was detected by western blot with the RBBP5 antibody diluted 1:500. Lane 3 shows the input (15% of the IP).

Figure 5. Immunohistochemistry using the Diagenode antibody directed against RBBP5
FFPE sections of human colon carcinoma tissue were analysed by Immunohistochemistry with the Diagenode antibody against RBBP5 (Cat. No. C15410342, lane 1) diluted 1:1,000.